Stefan Schulte,Rolf Spirig,Sabine Zollner,Michael Moses,Wilfried Wormsbaecher,Hans-Arnold Stoehr
申请号：
US14399326
公开号：
US09707269B2
申请日:
2013.03.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.
